Searched for
RECOMBINANT DNA TECHNOLOGY
Curb your overenthusiasm: Why India must avoid early overregulation while drafting rules for new techIndia faces a critical choice in regulating new industries like AI and genomics. Overly cautious, ex-ante regulations, similar to the histo...- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- Why I am an Opt'AI'mist: Human ingenuity has a fine track record, it should keep rogue tech in checkExperts warn of AI extinction risks. However, history shows past predictions of doom, like resource scarcity and nuclear winter, did not ma...
- IIT Guwahati researchers produce cardiac proteins to fix a damaged heartThe heart cells created using this toolbox can have the same function as the original heart cells and can be used to regenerate damaged hea...
- View: How Department of Biotechnology coordinated India's Covid-19 fightFrom its initial mandate to identify priority development areas in biotechnology, it has been instrumental in creating an academic ecosyste...
- View: Corona, wolf warriors create challenges and opportunities for IndiaWe didn’t pay adequate attention to Trump’s award of merit medals to the Quad prime ministers – it cemented the core of the Indo-Pacific as...
- 'Excellent safety' of 2 indigenous COVID candidate vaccines revealed during Phase-I trials: MinisterSerum Institute of India (SII) and ICMR have partnered for clinical development of two global vaccine candidates.
- GSK will price vaccine responsibly: Emmanuel Hanon, R&D HeadGSK said it was not expecting to profit from its collaborations on a vaccine candidate during the pandemic as the company rushes to offer 1...
- GSK, Sanofi team up to bring out Covid-19 vaccineTwo of the world's largest vaccine manufacturers, Sanofi and GlaxoSmithKline, are coming together to work on a Covid-19 vaccine, which if i...
- Sanofi joins hands with US govt to expedite development of coronavirus vaccineAs part of the initiative, the company said it will collaborate with Biomedical Advanced Research and Development Authority (BARDA) of the ...
- Rabishield: First fast-acting anti-rabies drug set for India launchRMAb has been developed by Pune-based Serum Institute of India (SII) and US-based Mass Biologics of the University of Massachusetts Medical...
- Bharat Biotech gets breakthrough in developing Zika vaccineBharat Biotech’s chief managing director Dr Krishna Ella said his company has ‘an early mover advantage’ in developing the Zika vaccine.
- Tamil Nadu Agri University to develop indegenous BT cotton in collaboraton with CICRTamil Nadu Agricultural University and Central Institute for Cotton Research (CICR) entered into agreement for developing indigenous BT Cot...
- Food inflation, inequity major challenges: SwaminathanFood inflation, increasing food production with existing and new technologies and ensuring equitable economic growth are the big challenges...
- ‘Innovation can only be funded by branded therapies’In an e-mail interview with ET, Henri A Termeer, Chairman, President & CEO of Genzyme Corporation discusses the latest trends in the area o...
- Biotech regulator needs engineeringIt is good news that the government is expediting the process of setting up the national biotechnology regulatory authority, which is envis...
- Mauritius-based FIIs to pick up 47% in Intas' biotech armA clutch of investors are set to pick up 47% stake in the Intas Biopharmaceuticals, the biotech arm of Ahmedabad-based pharma major Intas P...
- Bring rational regulatory regime for rDNA biotech productsThe modern biotech industry represents the accrual of economic benefits by the application of recombinant DNA.
- Advinus inaugurates new drug discovery facilityAdvinus Therapeutics, a joint venture between the Tata Group and ex-Ranbaxy research head Rashmi Barbhaiya, on Thursday inaugurated a drug ...
- Curbs imposed on GM drugs licensingWith an increasing number of drug companies seeking entry into the Indian market for recombinant technology-based drugs, regulators are tig...
Load More
